Clinical Trial Update: Botulinum Toxin for Trigeminal Neuralgia [Phase 3]

View source ↗

Summary

Phase 3 clinical trial update for botulinum toxin in trigeminal neuralgia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Trigeminal Neuralgia

Drugs mentioned

• Botulinum toxin (botulinum toxin)

Snippet

Sponsor: The First Affiliated Hospital of Zhengzhou University | Conditions: Trigeminal Neuralgia | Phase 3 | Status: UNKNOWN